The Small Protein RmpD Drives Hypermucoviscosity in <named-content content-type="genus-species">Klebsiella pneumoniae</named-content>

ABSTRACT Klebsiella pneumoniae has a remarkable ability to cause a wide range of human diseases. It is divided into two broad classes: classical strains that are a notable problem in health care settings due to multidrug resistance, and hypervirulent (hv) strains that are historically drug sensitive...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kimberly A. Walker, Logan P. Treat, Victoria E. Sepúlveda, Virginia L. Miller
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2020
Materias:
HMV
Acceso en línea:https://doaj.org/article/209942c105344f6e8186e47308c3054c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:209942c105344f6e8186e47308c3054c
record_format dspace
spelling oai:doaj.org-article:209942c105344f6e8186e47308c3054c2021-11-15T16:19:09ZThe Small Protein RmpD Drives Hypermucoviscosity in <named-content content-type="genus-species">Klebsiella pneumoniae</named-content>10.1128/mBio.01750-202150-7511https://doaj.org/article/209942c105344f6e8186e47308c3054c2020-10-01T00:00:00Zhttps://journals.asm.org/doi/10.1128/mBio.01750-20https://doaj.org/toc/2150-7511ABSTRACT Klebsiella pneumoniae has a remarkable ability to cause a wide range of human diseases. It is divided into two broad classes: classical strains that are a notable problem in health care settings due to multidrug resistance, and hypervirulent (hv) strains that are historically drug sensitive but able to establish disease in immunocompetent hosts. Alarmingly, there has been an increased frequency of clinical isolates that have both drug resistance and hv-associated genes. One such gene, rmpA, encodes a transcriptional regulator required for maximal capsule (cps) gene expression and confers hypermucoviscosity (HMV). This link has resulted in the assumption that HMV is caused by elevated capsule production. However, we recently reported a new cps regulator, RmpC, and ΔrmpC mutants have reduced cps expression but retain HMV, suggesting that capsule production and HMV may be separable traits. Here, we report the identification of a small protein, RmpD, that is essential for HMV but does not impact capsule. RmpD is 58 residues with a putative N-terminal transmembrane domain and highly positively charged C-terminal half, and it is conserved among other hv K. pneumoniae strains. Expression of rmpD in trans complements both ΔrmpD and ΔrmpA mutants for HMV, suggesting that RmpD is the key driver of this phenotype. The rmpD gene is located between rmpA and rmpC, within an operon regulated by RmpA. These data, combined with our previous work, suggest a model in which the RmpA-associated phenotypes are largely due to RmpA activating the expression of rmpD to produce HMV and rmpC to stimulate cps expression. IMPORTANCE Capsule is a critical virulence factor in Klebsiella pneumoniae, in both antibiotic-resistant classical strains and hypervirulent strains. Hypervirulent strains usually have a hypermucoviscosity (HMV) phenotype that contributes to their heightened virulence capacity, but the production of HMV is not understood. The transcriptional regulator RmpA is required for HMV and also activates capsule gene expression, leading to the assumption that HMV is caused by hyperproduction of capsule. We have identified a new gene (rmpD) required for HMV but not for capsule production. This distinction between HMV and capsule production will promote a better understanding of the mechanisms of hypervirulence, which is in great need given the alarming increase in clinical isolates with both drug resistance and hypervirulence traits.Kimberly A. WalkerLogan P. TreatVictoria E. SepúlvedaVirginia L. MillerAmerican Society for MicrobiologyarticleRmpARmpChypervirulentHMVcapsulehypermucoviscousMicrobiologyQR1-502ENmBio, Vol 11, Iss 5 (2020)
institution DOAJ
collection DOAJ
language EN
topic RmpA
RmpC
hypervirulent
HMV
capsule
hypermucoviscous
Microbiology
QR1-502
spellingShingle RmpA
RmpC
hypervirulent
HMV
capsule
hypermucoviscous
Microbiology
QR1-502
Kimberly A. Walker
Logan P. Treat
Victoria E. Sepúlveda
Virginia L. Miller
The Small Protein RmpD Drives Hypermucoviscosity in <named-content content-type="genus-species">Klebsiella pneumoniae</named-content>
description ABSTRACT Klebsiella pneumoniae has a remarkable ability to cause a wide range of human diseases. It is divided into two broad classes: classical strains that are a notable problem in health care settings due to multidrug resistance, and hypervirulent (hv) strains that are historically drug sensitive but able to establish disease in immunocompetent hosts. Alarmingly, there has been an increased frequency of clinical isolates that have both drug resistance and hv-associated genes. One such gene, rmpA, encodes a transcriptional regulator required for maximal capsule (cps) gene expression and confers hypermucoviscosity (HMV). This link has resulted in the assumption that HMV is caused by elevated capsule production. However, we recently reported a new cps regulator, RmpC, and ΔrmpC mutants have reduced cps expression but retain HMV, suggesting that capsule production and HMV may be separable traits. Here, we report the identification of a small protein, RmpD, that is essential for HMV but does not impact capsule. RmpD is 58 residues with a putative N-terminal transmembrane domain and highly positively charged C-terminal half, and it is conserved among other hv K. pneumoniae strains. Expression of rmpD in trans complements both ΔrmpD and ΔrmpA mutants for HMV, suggesting that RmpD is the key driver of this phenotype. The rmpD gene is located between rmpA and rmpC, within an operon regulated by RmpA. These data, combined with our previous work, suggest a model in which the RmpA-associated phenotypes are largely due to RmpA activating the expression of rmpD to produce HMV and rmpC to stimulate cps expression. IMPORTANCE Capsule is a critical virulence factor in Klebsiella pneumoniae, in both antibiotic-resistant classical strains and hypervirulent strains. Hypervirulent strains usually have a hypermucoviscosity (HMV) phenotype that contributes to their heightened virulence capacity, but the production of HMV is not understood. The transcriptional regulator RmpA is required for HMV and also activates capsule gene expression, leading to the assumption that HMV is caused by hyperproduction of capsule. We have identified a new gene (rmpD) required for HMV but not for capsule production. This distinction between HMV and capsule production will promote a better understanding of the mechanisms of hypervirulence, which is in great need given the alarming increase in clinical isolates with both drug resistance and hypervirulence traits.
format article
author Kimberly A. Walker
Logan P. Treat
Victoria E. Sepúlveda
Virginia L. Miller
author_facet Kimberly A. Walker
Logan P. Treat
Victoria E. Sepúlveda
Virginia L. Miller
author_sort Kimberly A. Walker
title The Small Protein RmpD Drives Hypermucoviscosity in <named-content content-type="genus-species">Klebsiella pneumoniae</named-content>
title_short The Small Protein RmpD Drives Hypermucoviscosity in <named-content content-type="genus-species">Klebsiella pneumoniae</named-content>
title_full The Small Protein RmpD Drives Hypermucoviscosity in <named-content content-type="genus-species">Klebsiella pneumoniae</named-content>
title_fullStr The Small Protein RmpD Drives Hypermucoviscosity in <named-content content-type="genus-species">Klebsiella pneumoniae</named-content>
title_full_unstemmed The Small Protein RmpD Drives Hypermucoviscosity in <named-content content-type="genus-species">Klebsiella pneumoniae</named-content>
title_sort small protein rmpd drives hypermucoviscosity in <named-content content-type="genus-species">klebsiella pneumoniae</named-content>
publisher American Society for Microbiology
publishDate 2020
url https://doaj.org/article/209942c105344f6e8186e47308c3054c
work_keys_str_mv AT kimberlyawalker thesmallproteinrmpddriveshypermucoviscosityinnamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontent
AT loganptreat thesmallproteinrmpddriveshypermucoviscosityinnamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontent
AT victoriaesepulveda thesmallproteinrmpddriveshypermucoviscosityinnamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontent
AT virginialmiller thesmallproteinrmpddriveshypermucoviscosityinnamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontent
AT kimberlyawalker smallproteinrmpddriveshypermucoviscosityinnamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontent
AT loganptreat smallproteinrmpddriveshypermucoviscosityinnamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontent
AT victoriaesepulveda smallproteinrmpddriveshypermucoviscosityinnamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontent
AT virginialmiller smallproteinrmpddriveshypermucoviscosityinnamedcontentcontenttypegenusspeciesklebsiellapneumoniaenamedcontent
_version_ 1718426892280791040